The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Open accessAbstract
Drug-target interaction (DTI) is the basis of drug discovery and design. It is time consuming and costly to determine DTI experimentally. Hence, it is necessary to develop computational methods for the prediction of potential DTI. Based on complex network theory, three supervised inference methods were developed here to predict DTI and used for drug repositioning, namely drug-based similarity inference (DBSI), target-based similarity inference (TBSI) and network-based inference (NBI). Among them, NBI performed best on four benchmark data sets. Then a drug-target network was created with NBI based on 12,483 FDA-approved and experimental drug-target binary links, and some new DTIs were further predicted. In vitro assays confirmed that five old drugs, namely montelukast, diclofenac, simvastatin, ketoconazole, and itraconazole, showed polypharmacological features on estrogen receptors or dipeptidyl peptidase-IV with half maximal inhibitory or effective concentration ranged from 0.2 to 10 µM. Moreover, simvastatin and ketoconazole showed potent antiproliferative activities on human MDA-MB-231 breast cancer cell line in MTT assays. The results indicated that these methods could be powerful tools in prediction of DTIs and drug repositioning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Item-based collaborative filtering recommendation algorithms
Sarwar, B., Karypis, G., Konstan, J., & Riedl, J. (2001) · Proceedings of the 10th international conference on World Wide Web · doi:10.1145/371920.372071 · Cited by 9,135 · cited 1×
“In principle, the DBSI method (Figure 1A) is very similar to the item-based collaborative filtering method in recommendation algorithms [20], while TBSI (Figure 1B) is similar to the user-based collaborative filtering method [21].”
MethodEvaluating collaborative filtering recommender systems
Herlocker, J. L., Konstan, J. A., Terveen, L. G., & Riedl, J. T. (2004) · ACM Transactions on Information Systems · doi:10.1145/963770.963772 · Cited by 5,798 · cited 2×
“In this study, three inference methods were developed to predict new DTI: drug-based similarity inference (DBSI), target-based similarity inference (TBSI) and network-based inference (NBI), all derived from complex network theory [18–21].”
MethodNetwork medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“We are actively developing new network inference method by integrating drugs, proteins and phenotype features based on diffusion theory [32].”
MethodNetwork pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders
Hamosh, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki033 · Cited by 3,420
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,120
Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method
Daniel Gietz, R., & Woods, R. A. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)50957-5 · Cited by 2,871
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Cited by
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Self-citationStructure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Zitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
Tang, J., Szwajda, A., Shakyawar, S., Xu, T., Hintsanen, P., Wennerberg, K., & Aittokallio, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400709d · Cited by 645
Network-based in silico drug efficacy screening
Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016) · Nature Communications · doi:10.1038/ncomms10331 · Cited by 625
“The increasing interest in reusing existing drugs for novel therapies has recently given rise to various approaches that aim to identify candidate drugs with similar characteristics to known drugs used in a disease 7,8,19–20 .”
Deep-Learning-Based Drug–Target Interaction Prediction
Wen, M., Zhang, Z., Niu, S., Sha, H., Yang, R., Yun, Y., & Lu, H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00618 · Cited by 576
Toward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 559
deepDR: a network-based deep learning approach to in silico drug repositioning
Zeng, X., Zhu, S., Liu, X., Zhou, Y., Nussinov, R., & Cheng, F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz418 · Cited by 535
Self-citationYao, Z.-J., Dong, J., Che, Y.-J., Zhu, M.-F., Wen, M., Wang, N.-N., Wang, S., Lu, A.-P., & Cao, D.-S. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9915-2 · Cited by 514
Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm
Luo, H., Wang, J., Li, M., Luo, J., Peng, X., Wu, F.-X., & Pan, Y. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw228 · Cited by 477
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427
Jin, G., & Wong, S. T. C. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.005 · Cited by 416
Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction
Liu, Y., Wu, M., Miao, C., Zhao, P., & Li, X.-L. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004760 · Cited by 391
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X.-L., & Zheng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 382
Cheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
Self-citationImproving compound–protein interaction prediction by building up highly credible negative samples
Liu, H., Sun, J., Guan, J., Zheng, J., & Zhou, S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv256 · Cited by 359
Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., Zmoos, A.-F., Vaka, D., Tran, K. Q. T., Zhou, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0183 · Cited by 358
Target identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357
Self-citationDrug repositioning by integrating target information through a heterogeneous network model
Wang, W., Yang, S., Zhang, X., & Li, J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu403 · Cited by 335
Identifying drug–target interactions based on graph convolutional network and deep neural network
Zhao, T., Hu, Y., Valsdottir, L. R., Zang, T., & Peng, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa044 · Cited by 332
A review of network-based approaches to drug repositioning
Lotfi Shahreza, M., Ghadiri, N., Mousavi, S. R., Varshosaz, J., & Green, J. R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx017 · Cited by 330
In silico methods for drug repurposing and pharmacology
Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1337 · Cited by 326
Ezzat, A., Wu, M., Li, X.-L., & Kwoh, C.-K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby002 · Cited by 314
The significance of artificial intelligence in drug delivery system design
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.001 · Cited by 305
A review of computational drug repurposing
Park, K. (2019) · Translational and Clinical Pharmacology · doi:10.12793/tcp.2019.27.2.59 · Cited by 300
Drug repurposing in oncology—patient and health systems opportunities
Bertolini, F., Sukhatme, V. P., & Bouche, G. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.169 · Cited by 294
Machine Learning for Drug-Target Interaction Prediction
Chen, R., Liu, X., Jin, S., Lin, J., & Liu, J. (2018) · Molecules · doi:10.3390/molecules23092208 · Cited by 292
Methods for biological data integration: perspectives and challenges
Gligorijević, V., & Pržulj, N. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0571 · Cited by 275
Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein
Strating, J. R. P. M., van der Linden, L., Albulescu, L., Bigay, J., Arita, M., Delang, L., Leyssen, P., van der Schaar, H. M., Lanke, K. H. W., Thibaut, H. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.054 · Cited by 258
Compact integration of multi-network topology for functional analysis of genes
Cho, H., Berger, B., & Peng, J. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.017 · Cited by 241
Predicting drug-target interaction network using deep learning model
You, J., McLeod, R. D., & Hu, P. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.03.016 · Cited by 150
Design of efficient computational workflows for in silico drug repurposing
Vanhaelen, Q., Mamoshina, P., Aliper, A. M., Artemov, A., Lezhnina, K., Ozerov, I., Labat, I., & Zhavoronkov, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.019 · Cited by 150
Thafar, M. A., Olayan, R. S., Ashoor, H., Albaradei, S., Bajic, V. B., Gao, X., Gojobori, T., & Essack, M. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00447-2 · Cited by 143
Exploration of databases and methods supporting drug repurposing: a comprehensive survey
Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa003 · Cited by 131
Comprehensive prediction of drug-protein interactions and side effects for the human proteome
Zhou, H., Gao, M., & Skolnick, J. (2015) · Scientific Reports · doi:10.1038/srep11090 · Cited by 138
Peng, J., Li, J., & Shang, X. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03677-1 · Cited by 133
Adverse drug events: database construction and in silico prediction
Cheng, F., Li, W., Wang, X., Zhou, Y., Wu, Z., Shen, J., & Tang, Y. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4000079 · Cited by 124
Self-citationTaubes, A., Nova, P., Zalocusky, K. A., Kosti, I., Bicak, M., Zilberter, M. Y., Hao, Y., Yoon, S. Y., Oskotsky, T., Pineda, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00122-7 · Cited by 118
“…was also detected by De analysis of snrNA-seq in the apoe4-KI mouse hippocampus after bumetanide treatment as compared to controls in combined data from all neuronal clusters that exhibited a significant “flip” of human apoe4/4 AD genes (Clusters 1, 2, 3, 4, 5, 6, 8, 9, 10, 13, and 16 combined ) .”
BackgroundAdvancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Drug–target interaction predication via multi-channel graph neural networks
Li, Y., Qiao, G., Wang, K., & Wang, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab346 · Cited by 112
Tsuji, S., Hase, T., Yachie-Kinoshita, A., Nishino, T., Ghosh, S., Kikuchi, M., Shimokawa, K., Aburatani, H., Kitano, H., & Tanaka, H. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00826-3 · Cited by 75
Zhou, H., Cao, H., & Skolnick, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00309 · Cited by 39
Wang, R., Li, S., Cheng, L., Wong, M. H., & Leung, K. S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3283-6 · Cited by 37
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
Issa, N. T., Kruger, J., Wathieu, H., Raja, R., Byers, S. W., & Dakshanamurthy, S. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1065-y · Cited by 22
Cao, D.-S., Jiang, S.-L., Guan, Y.-D., Chen, X.-S., Zhang, L.-X., Zhang, Y., Chen, A. F., Yang, J.-M., & Cheng, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112421 · Cited by 16
Hansson, F. G., Madsen, N. G., Hansen, L. G., Jakočiūnas, T., Lengger, B., Keasling, J. D., Jensen, M. K., Acevedo-Rocha, C. G., & Jensen, E. D. (2025) · Nature Communications · doi:10.1038/s41467-025-59418-6 · Cited by 7
Metadata
- Authors
- Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y.
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-10
- Volume
- 8
- Issue
- 5
- Pages
- e1002503
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- OpenAlex
- W1984084871
- Cited by
- 818
- References
- 53
- FWCI
- 49.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.